Mangiferin Inhibits Human Lung Adenocarcinoma by Suppressing MiR-27b and MiR-92a

Xiao-Jv Chi1, Jian-Jun Meng2, Chun-Yu Lin1

  • 1Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road, Nanning, Guangxi Zhuang Autonomous Region 530021, China.

Insights

Mangiferin, a natural compound, inhibits lung adenocarcinoma (LUAD) cell growth and promotes apoptosis. It appears to achieve this by downregulating miR-92a and miR-27b expression in LUAD cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Lung adenocarcinoma (LUAD) is a common cancer with unclear mechanisms and treatment strategies.
  • Mangiferin, a flavonoid from mango leaves, possesses various pharmacological effects.
  • Understanding mangiferin's role in LUAD is crucial for developing new therapies.

Purpose of the Study:

  • To investigate the biological effects of mangiferin on LUAD cell lines.
  • To elucidate the in vitro mechanism of mangiferin's action in LUAD.
  • To explore the potential role of specific microRNAs in mangiferin's anti-cancer activity.

Main Methods:

  • Mangiferin treatment of LUAD cell lines (A549, H1299, H2030).
  • Cell proliferation assays and cell cycle analysis (G1/S phase).
  • Microarray and micro-RNA sequencing to identify differentially expressed microRNAs.

Main Results:

  • Mangiferin significantly inhibited LUAD cell proliferation in a dose- and time-dependent manner.
  • Mangiferin induced apoptosis and caused cell cycle arrest at G1 and S phases.
  • Mangiferin treatment correlated with downregulated levels of miR-92a and miR-27b, which are upregulated in LUAD tissues.

Conclusions:

  • Mangiferin exhibits anti-proliferative and pro-apoptotic effects on LUAD cells.
  • Mangiferin's mechanism involves the downregulation of miR-92a and miR-27b.
  • Mangiferin shows potential as a therapeutic agent for lung adenocarcinoma.